Synthon hires CXO x2
This article was originally published in Scrip
Executive Summary
Synthon, a generic pharmaceuticals company, has appointed Dr Ian Anderson chief scientific officer and Dr Leon Hooftman chief medical officer. Dr Anderson most recently served as vice-president and global head of respiratory inflammation and autoimmunity at MedImmune, and Dr Hooftman was previously CMO at Opsona Therapeutics.